VITA 34 AG (VTIAF)
USD 5.99
(0.0%)
USD 5.99
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 3.38 Million EUR | -71.9% |
| 2022 | 12.05 Million EUR | -38.83% |
| 2021 | 19.7 Million EUR | 505.62% |
| 2020 | 3.25 Million EUR | -36.89% |
| 2019 | 5.15 Million EUR | -4.2% |
| 2018 | 5.38 Million EUR | -28.21% |
| 2017 | 7.49 Million EUR | 386.19% |
| 2016 | 1.54 Million EUR | -29.14% |
| 2015 | 2.17 Million EUR | 1226.83% |
| 2014 | 164 Thousand EUR | -21.9% |
| 2013 | 210 Thousand EUR | -39.83% |
| 2012 | 349 Thousand EUR | -80.72% |
| 2011 | 1.81 Million EUR | 2.84% |
| 2010 | 1.76 Million EUR | -23.97% |
| 2009 | 2.31 Million EUR | 54.33% |
| 2008 | 1.5 Million EUR | -7.69% |
| 2007 | 1.62 Million EUR | 0.0% |
| 2006 | - EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 3.16 Million EUR | -6.55% |
| 2024 Q2 | 2.84 Million EUR | -9.98% |
| 2023 Q2 | 12.58 Million EUR | 7.59% |
| 2023 FY | 3.38 Million EUR | -71.9% |
| 2023 Q3 | 11.93 Million EUR | -5.15% |
| 2023 Q1 | 11.69 Million EUR | -2.95% |
| 2023 Q4 | 3.38 Million EUR | -71.63% |
| 2022 Q3 | 12 Million EUR | -33.49% |
| 2022 Q4 | 12.05 Million EUR | 0.44% |
| 2022 FY | 12.05 Million EUR | -38.83% |
| 2022 Q1 | 19.38 Million EUR | -1.65% |
| 2022 Q2 | 18.04 Million EUR | -6.9% |
| 2021 FY | 19.7 Million EUR | 505.62% |
| 2021 Q1 | 2.81 Million EUR | -13.4% |
| 2021 Q2 | 2.34 Million EUR | -16.96% |
| 2021 Q3 | 1.83 Million EUR | -21.54% |
| 2021 Q4 | 19.7 Million EUR | 973.37% |
| 2020 FY | 3.25 Million EUR | -36.89% |
| 2020 Q2 | 4.18 Million EUR | -10.61% |
| 2020 Q3 | 3.69 Million EUR | -11.55% |
| 2020 Q4 | 3.25 Million EUR | -12.01% |
| 2020 Q1 | 4.67 Million EUR | -9.29% |
| 2019 Q2 | 5.21 Million EUR | -8.91% |
| 2019 Q3 | 4.71 Million EUR | -9.61% |
| 2019 Q4 | 5.15 Million EUR | 9.42% |
| 2019 FY | 5.15 Million EUR | -4.2% |
| 2019 Q1 | 5.72 Million EUR | 6.34% |
| 2018 Q1 | 7.96 Million EUR | 6.22% |
| 2018 Q4 | 5.38 Million EUR | -15.07% |
| 2018 Q3 | 6.33 Million EUR | -6.55% |
| 2018 Q2 | 6.78 Million EUR | -14.84% |
| 2018 FY | 5.38 Million EUR | -28.21% |
| 2017 Q2 | 9.07 Million EUR | 508.24% |
| 2017 Q3 | 8.63 Million EUR | -4.88% |
| 2017 FY | 7.49 Million EUR | 386.19% |
| 2017 Q4 | 7.49 Million EUR | -13.15% |
| 2017 Q1 | 1.49 Million EUR | -3.24% |
| 2016 FY | 1.54 Million EUR | -29.14% |
| 2016 Q4 | 1.54 Million EUR | -20.47% |
| 2016 Q3 | 1.93 Million EUR | -4.62% |
| 2016 Q2 | 2.03 Million EUR | -4.46% |
| 2016 Q1 | 2.12 Million EUR | -2.21% |
| 2015 FY | 2.17 Million EUR | 1226.83% |
| 2015 Q4 | 2.17 Million EUR | 168.97% |
| 2015 Q2 | 998 Thousand EUR | 17.69% |
| 2015 Q3 | 809 Thousand EUR | -18.94% |
| 2015 Q1 | 848 Thousand EUR | 417.07% |
| 2014 Q1 | 193 Thousand EUR | -8.1% |
| 2014 Q4 | 164 Thousand EUR | 2.5% |
| 2014 FY | 164 Thousand EUR | -21.9% |
| 2014 Q3 | 160 Thousand EUR | -9.6% |
| 2014 Q2 | 177 Thousand EUR | -8.29% |
| 2013 Q3 | 348 Thousand EUR | 0.29% |
| 2013 FY | 210 Thousand EUR | -39.83% |
| 2013 Q4 | 210 Thousand EUR | -39.66% |
| 2013 Q2 | 347 Thousand EUR | 3.89% |
| 2013 Q1 | 334 Thousand EUR | -4.3% |
| 2012 Q4 | 349 Thousand EUR | -50.36% |
| 2012 Q1 | 1.29 Million EUR | -28.4% |
| 2012 Q2 | 719 Thousand EUR | -44.52% |
| 2012 Q3 | 703 Thousand EUR | -2.23% |
| 2012 FY | 349 Thousand EUR | -80.72% |
| 2011 Q1 | 2.45 Million EUR | 39.66% |
| 2011 FY | 1.81 Million EUR | 2.84% |
| 2011 Q2 | 2.31 Million EUR | -5.9% |
| 2011 Q3 | 1.68 Million EUR | -27.02% |
| 2011 Q4 | 1.81 Million EUR | 7.23% |
| 2010 FY | 1.76 Million EUR | -23.97% |
| 2010 Q4 | 1.76 Million EUR | 34.15% |
| 2010 Q3 | 1.31 Million EUR | 0.0% |
| 2010 Q2 | 1.31 Million EUR | -4.58% |
| 2010 Q1 | 1.37 Million EUR | -40.6% |
| 2009 Q4 | 2.31 Million EUR | 0.0% |
| 2009 Q2 | 1.43 Million EUR | 0.0% |
| 2009 FY | 2.31 Million EUR | 54.33% |
| 2008 FY | 1.5 Million EUR | -7.69% |
| 2007 FY | 1.62 Million EUR | 0.0% |
| 2006 FY | - EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| The Amacore Group, Inc. | 1.82 Million USD | -85.44% |
| Arem Pacific Corporation | 151.51 Thousand USD | -2135.452% |
| Assisted 4 Living, Inc. | - USD | -Infinity% |
| BioCorRx Inc. | 3.89 Million USD | 13.047% |
| Bionik Laboratories Corp. | 2.39 Million USD | -41.701% |
| Banyan Corp. | 2.43 Million USD | -39.299% |
| Clearday, Inc. | 25.8 Million USD | 86.877% |
| Dental Patient Care America, Inc. | - USD | -Infinity% |
| Quantum Medical Transport, Inc. | - USD | -Infinity% |
| Empower Clinics Inc. | 1.93 Million USD | -75.416% |
| First Choice Healthcare Solutions, Inc. | 1.28 Million USD | -163.862% |
| Selectis Health, Inc. | 25.17 Million USD | 86.547% |
| Ethema Health Corporation | 20.52 Thousand USD | -16405.848% |
| HealthLynked Corp. | 450 Thousand USD | -652.667% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | - USD | -Infinity% |
| JRSIS Health Care Corporation | 24.95 Thousand USD | -13475.15% |
| Comjoyful International Company | - USD | -Infinity% |
| Medical Facilities Corporation | 54.46 Million USD | 93.782% |
| MedSmart Group Inc. | 50 Thousand USD | -6674.0% |
| North America Frac Sand, Inc. | - USD | -Infinity% |
| Nova Leap Health Corp. | 914.05 Thousand USD | -270.546% |
| Nexteligent Holdings, Inc. | - USD | -Infinity% |
| PAO Group, Inc. | - USD | -Infinity% |
| Primemd Inc. | 6.89 Million USD | 50.875% |
| Raffles Medical Group Ltd | 52.43 Million USD | 93.541% |
| Ryman Healthcare Limited | 1.52 Billion USD | 99.778% |
| Stem Cell Authority, Ltd. | - USD | -Infinity% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 57.07 Thousand USD | -5833.881% |
| Mycotopia Therapies, Inc. | - USD | -Infinity% |
| U.S. NeuroSurgical Holdings, Inc. | 58 Thousand USD | -5739.655% |
| Veltex Corporation | - USD | -Infinity% |
| World Financial Holding Group | - USD | -Infinity% |
| Xcelerate Inc. | - USD | -Infinity% |